Home  
  Research  
  Clinic  
   
   
 
  Donations  
  About Us  
 
Hope logo
The newsletter of
The Stehlin Foundation
 
  


Contact us:

The Stehlin Foundation
for Cancer Research
1315 St. Joseph Parkway,
Suite 1818
Houston, Texas 77002
Phone 713-659-1336
FAX 713-659-1503
http://www.stehlin.org

 
 

 

 

BACK to June 2005 HOPE Newsletter Contents


Saying NO to the Status Quo

Patrick Scranton, diagnosed with DSRCT in 2003, became an active participant in providing information and funding research on the disease.



































Imagine you are Patrick Scranton – a 40-year-old, vital, energetic entrepreneur – and you become the oldest person ever diagnosed with DSRCT, an aggressive form of cancer that strikes mostly juveniles. Imagine that you can’t really find much information about the rare disease. Imagine being frustrated by debilitating treatments and feeling strongly that there must be an alternative. What do you do?

What Patrick did was start his own campaign to, first, gather and provide as much information as possible to other patients via the Internet, and, second, to provide funding for continued research into the disease and its treatment.

Diagnosed in 2003, Patrick launched a DSRCT web site (www.dsrct.com) in April of 2004. “My goal was to create a place where everyone on the planet who had this disease could share their experiences and the options for treatment. It can save people thousands of hours of time.”

Patrick was well into a traditional cancer treatment program when he learned
about the research on human tumors used at the Stehlin Foundation. “With my short
time frame, I was intrigued by the idea of research paying off immediately,” he said.


As a result of his findings, Patrick decided to help fund the Stehlin Foundation’s DSRCT tumor cancer study, where patients send samples of their tumors to be grown in nude mice and tested for various treatments. “I am specifically interested in the Foundation’s role as a clearinghouse for DSRCT information to be shared by everyone,” he said.

DSRCT patients who log onto Patrick’s web site are encouraged to become part of the Stehlin study, and Patrick’s family has been helping with the fundraising efforts. “The results may actually be too late for me,” said Patrick, “but the Stehlin Foundation has the people and approach to make a real leap in cancer treatment.”


After a long and courageous battle with DSRCT, Patrick Scranton died May 5, 2005.
A tireless friend of the Stehlin Foundation and DSRCT patients and families everywhere, Patrick will be sorely missed.

BACK to June 2005 HOPE Newsletter Contents


Home / Research / Clinic / Fundraising / News Room / Donations / About Us
Comments? Mail to:
Webmaster: Doug Coil
dcoil@stehlin.org